#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Dylan Daniel Email
VP, Oncology & Immuno-Oncology Research and Translational Biology . CytomX Therapeutics
South San Francisco, CA
LocationPrimary Email
How to contact Dylan Daniel
Join and see Dylan's contact info for free!Phone
Current Roles
Employees:
150Revenue:
$66.2MAbout
CytomX Therapeutics is a clinical-stage biopharmaceutical company with a deep and differentiated oncology pipeline of investigational Probody therapeutics. Probody therapeutics are designed to exploit unique conditions of the tumor microenvironment to more effectively localize antibody binding and activity while limiting activity in healthy tissues. The Company's pipeline includes proprietary cancer immunotherapies against clinically-validated targets, such as PD-L1, and first-in-class Probody drug conjugates against highly attractive targets, such as CD166 and CD71, which are considered to be inaccessible to conventional antibody drug conjugates due to their presence on healthy tissue. In addition to its wholly owned programs, CytomX has strategic collaborations with AbbVie, Amgen, Bristol-Myers Squibb Company, MD Anderson Cancer Center and ImmunoGen, Inc. For more information, visit www.cytomx.com or follow us on Twitter.CytomX Therapeutics Address
151 Oyster Point BlvdSouth San Francisco, CA
United States